1 Answer

0 votes
ago by
According to the latest trends in the market, it is predicted that there will be a drop in the patient expirations for small molecule drugs. So, the best thing pharma industries can do is to go for generic drug manufacturing. Here, the 505(B)(2) Licensing Opportunity will be of great help to them in creating a new stream of revenue.

AnswerHighway.com is a community driven question and answer site - Ask questions and answer questions across a large range of categories

The opinions expressed on this page are the views of the author, and not necessarily the views of AnswerHighway.com, its staff, or its partners.